
Keywords: Chronic heart failure (CHF); Sheng Mai Yin (SMY); Matrix metalloproteinases (MMPs); Tumor necrosis factor-α (TNF-α); interleukin-6 (IL-6); CA; Captopril administration group; CHF; Chronic heart failure; CHFM; CHF model group; COL-IV; Collagen-IV; CON; C